MERONI, MARINA

MERONI, MARINA  

DIPARTIMENTO DI BIOTECNOLOGIE E BIOSCIENZE  

Mostra records
Risultati 1 - 19 di 19 (tempo di esecuzione: 0.033 secondi).
Titolo Tipologia Data di pubblicazione Autori File
Abstract 7199: The retinoid X receptor (RXR) agonist IRX4204 potentiates the efficacy of trabectedin and pioglitazone in myxoid liposarcoma preclinical models 02 - Intervento a convegno 2024 Meroni, Marina +
Distribution of pamiparib, a novel inhibitor of poly(ADP-ribose)-polymerase (PARP), in tumor tissue analyzed by multimodal imaging 01 - Articolo su rivista 2024 Morosi, LaviniaMeroni, Marina +
Induction of adipocytic differentiation in myxoid liposarcoma: new approaches to improve the effectiveness of the available therapies 02 - Intervento a convegno 2024 M. Meroni +
Mechanism of efficacy of trabectedin against myxoid liposarcoma entails detachment of the FUS-DDIT3 transcription factor from its DNA binding sites 01 - Articolo su rivista 2024 Ballabio, SaraMeroni, MarinaPonzo, Marianna +
MSIpixel: a fully automated pipeline for compound annotation and quantitation in mass spectrometry imaging experiments 01 - Articolo su rivista 2024 Meroni, M +
Chemotherapy-induced neutropenia elicits metastasis formation in mice by promoting proliferation of disseminated tumor cells 01 - Articolo su rivista 2023 Laura FormentiMarina Meroni +
Enhancing Pt(IV) Complexes' Anticancer Activity upon Encapsulation in Stimuli‐Responsive Nanocages 01 - Articolo su rivista 2023 Meroni, Marina +
The combination of the PPARγ agonist pioglitazone and the RXR agonist IRX4204 induces adipocytic differentiation in myxoid liposarcoma 02 - Intervento a convegno 2023 Meroni, M +
The combination of the PPARγ agonist pioglitazone and the RXR agonist IRX4204 induces adipocytic differentiation in myxoid liposarcoma. 02 - Intervento a convegno 2023 M. Meroni +
Corrigendum to “Mechanisms of responsiveness to and resistance against trabectedin in murine models of human myxoid liposarcoma” [Genomics Volume 113, Issue 5, September 2021, Pages 3439–3448] (Genomics (2021) 113(5) (3439–3448), (S0888754321003062), (10.1016/j.ygeno.2021.07.028)) 99 - Altro 2022 Meroni M. +
Development and Validation of a HPLC–MS/MS Method to Measure Nifuroxazide and Its Application in Healthy and Glioblastoma-Bearing Mice 01 - Articolo su rivista 2022 Meroni, Marina +
Establishment and characterization of a new panel of uterine leiomyosarcoma patient-derived xenograft models 02 - Intervento a convegno 2022 Marina MeroniMaria Chiara Barbera +
Pharmacokinetic evaluation of trabectedin and pioglitazone combination in myxoid liposarcoma patient-derived xenografts. 02 - Intervento a convegno 2022 M. Meroni +
Pharmacokinetics of the combination of trabectedin and pioglitazone in myxoid liposarcoma patient-derived xenograft models 02 - Intervento a convegno 2022 Meroni, MarinaMorosi, Lavinia +
Quantitative measurement of pioglitazone in neoplastic and normal tissues by AP-MALDI mass spectrometry imaging 01 - Articolo su rivista 2022 Meroni, M +
Betulinic acid and its spray dried microparticle formulation: In vitro PDT effect against ovarian carcinoma cell line and in vivo plasma and tumor disposition 01 - Articolo su rivista 2021 Meroni, Marina +
Inhibition of tumor-associated macrophages by trabectedin improves the antitumor adaptive immunity in response to anti-PD-1 therapy 01 - Articolo su rivista 2021 Meroni, M +
Mechanisms of responsiveness to and resistance against trabectedin in murine models of human myxoid liposarcoma 01 - Articolo su rivista 2021 Ballabio S.Meroni M.Callari M. +
PEGylated recombinant human hyaluronidase (PEGPH20) pre-treatment improves intra-tumour distribution and efficacy of paclitaxel in preclinical models 01 - Articolo su rivista 2021 Meroni M. +